insights_auto
Why is CYTK down 2,15%?
Dive Deeperchevron_right
CYTK:NASDAQ
Cytokinetics, Inc.
61,35 USD
arrow_downward
-2,15%(-1,35) 1D
61,35 USD
0,00% (0,00)
bedtimeAfter hours
Closed: 6-окт., 16:00:01 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CYTK...
Open
62,20 USD
High
62,52 USD
Low
60,68 USD
Mkt. cap
8,92 млд
Avg. vol.
2,09 млн
Volume
3,18 млн
52-wk high
88,31 USD
52-wk low
54,30 USD
EPS
-7,22 USD
Beta
0,41
Shares outstanding
139,02 млн
No. of employees
673
Open
62,20 USD
High
62,52 USD
Low
60,68 USD
Mkt. cap
8,92 млд
Avg. vol.
2,09 млн
Volume
3,18 млн
52-wk high
88,31 USD
52-wk low
54,30 USD
EPS
-7,22 USD
Beta
0,41
Shares outstanding
139,02 млн
No. of employees
673
News stories
From web sources and news partners
AD HOC NEWS
·
9 саат мурун
Cytokinetics announces four HFSA presentations: 18 analysts rate Cytokinetics stock Buy
Profile
Cytokinetics, Incorporated, is a biopharmaceutical company based in South San Francisco, California, that develops muscle activators and muscle inhibitors as potential treatments for people with diseases characterized by impaired or declining muscle function. Wikipedia
About Cytokinetics, Inc.
CEORobert I. Blum | Robert I. Blum
Employees673
Founded1997
HeadquartersЮг Сан Франциско, Калифорния, Америка Кошмо Штаттары
Sector-
Websitecytokinetics.com